These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26202421)

  • 1. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
    Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
    Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear, not cytoplasmic, PKR maneuvers in AML.
    Oshima M; Iwama A
    Blood; 2015 Sep; 126(13):1523-4. PubMed ID: 26405214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.
    Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
    Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
    Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.
    Yin M; Baslan T; Walker RL; Zhu YJ; Freeland A; Matsukawa T; Sridharan S; Nussenzweig A; Pruitt SC; Lowe SW; Meltzer PS; Aplan PD
    JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31622281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
    Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
    Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
    Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
    Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
    Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
    Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant
    Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
    Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.
    Humeniuk R; Koller R; Bies J; Aplan P; Wolff L
    Stem Cells; 2014 May; 32(5):1361-6. PubMed ID: 24449168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
    Cagnetta A; Soncini D; Orecchioni S; Talarico G; Minetto P; Guolo F; Retali V; Colombo N; Carminati E; Clavio M; Miglino M; Bergamaschi M; Nahimana A; Duchosal M; Todoerti K; Neri A; Passalacqua M; Bruzzone S; Nencioni A; Bertolini F; Gobbi M; Lemoli RM; Cea M
    Haematologica; 2018 Jan; 103(1):80-90. PubMed ID: 29025907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
    Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
    Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
    Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
    J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.
    Choi CW; Chung YJ; Slape C; Aplan PD
    J Immunol; 2009 Nov; 183(10):6227-35. PubMed ID: 19841179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.
    Balderman SR; Li AJ; Hoffman CM; Frisch BJ; Goodman AN; LaMere MW; Georger MA; Evans AG; Liesveld JL; Becker MW; Calvi LM
    Blood; 2016 Feb; 127(5):616-25. PubMed ID: 26637787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
    Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
    Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
    Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
    J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.
    Gu BW; Wang Q; Wang JM; Xue YQ; Fang J; Wong KF; Chen B; Shi ZZ; Shi JY; Bai XT; Wu DH; Chen Z; Chen SJ
    Leukemia; 2003 Sep; 17(9):1858-64. PubMed ID: 12970787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.